Have a personal or library account? Click to login
Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals Cover

Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals

Radiology and Oncology
Volume 52 (2018): Issue 3 (September 2018)
By: Borut Kobal,  Marco Noventa,  Branko Cvjeticanin,  Matija Barbic,  Leon Meglic,  Marusa Herzog,  Giulia Bordi,  Amerigo Vitagliano,  Carlo Saccardi and  Erik Skof  
Open Access
|Sep 2018

Metrics

DOI: https://doi.org/10.2478/raon-2018-0030 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 307 - 319
Submitted on: Mar 28, 2018
|
Accepted on: Jul 23, 2018
|
Published on: Sep 11, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
epithelial ovarian cancer,
advanced stage,
primary debulking surgery,
interval debulking surgery,
neoadjuvant chemotherapy,
adjuvant chemotherapy,
overall survival,
progression free survival
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Borut Kobal, Marco Noventa, Branko Cvjeticanin, Matija Barbic, Leon Meglic, Marusa Herzog, Giulia Bordi, Amerigo Vitagliano, Carlo Saccardi, Erik Skof, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 3 (September 2018)Next article